AOD-9604 vs Semax
A comprehensive, data-driven comparison of AOD-9604 (Advanced Obesity Drug) and Semax. Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | AOD-9604 Advanced Obesity Drug, Tyr-hGH Fragment 176-191 | Semax |
|---|---|---|
| FDA Status | Phase 2 (failed; reclassification pending) | Not submitted |
| Category | Weight Loss | Cognitive Enhancement |
| Primary Use | Fat loss and metabolism enhancement | Cognitive enhancement and neuroprotection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $60/mo | $45 - $90/mo |
| Administration | Subcutaneous injection | Nasal spray |
| Typical Dose | 300mcg daily | 2-3 drops per nostril 2-3x daily |
| Frequency | Daily | Daily |
| Mechanism | Modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis without affecting blood sugar or IGF-1 | Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Moderate |
| Clinical Trial Phase | Phase 2 | N/A |
Key Differences
- 1AOD-9604 is generally more affordable ($30 - $60/mo) compared to Semax ($45 - $90/mo).
- 2AOD-9604 is administered via subcutaneous injection, while Semax uses nasal spray.
- 3Semax has moderate-quality evidence, while AOD-9604 has low-quality evidence.
- 4They belong to different categories: AOD-9604 (Weight Loss) vs Semax (Cognitive Enhancement).
Which Is Better For...
AOD-9604
More budget-friendly option with lower monthly costs
AOD-9604
Fewer commonly reported side effects
Semax
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| AOD-9604 | $30 - $60/mo | Phase 2 (failed; reclassification pending) | Various research labs |
| Semax | $45 - $90/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
AOD-9604 works via Modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis. Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. They differ in FDA approval status, efficacy data, and cost.
AOD-9604 typically costs $30 - $60/mo, while Semax costs $45 - $90/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
AOD-9604 is not FDA-approved (Phase 2 (failed; reclassification pending)). Semax is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of AOD-9604 include Injection site reactions, Headache, Chest tightness (rare). Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
AOD-9604 is a modified peptide fragment of the C-terminus of human growth hormone (amino acids 176-191). It was designed to retain the fat-burning properties of HGH while avoiding effects on blood sug...
View Full AOD-9604 GuideSemax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and ...
View Full Semax GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between AOD-9604 and Semax should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.